There's hope for those with end-stage kidney disease, as a new transplant method was unveiled this week

The eGenesis company of Cambridge, MA is in the midst of trials for the EGEN-2784, a new artificial kidney transplant method unveiled this week

If successful, global organ shortage, the EGEN-2784 could help end the global organ shortage

Science just scored a win regarding the fight against end-stage kidney disease.

The eGenesis company of Cambridge, MA announced Sept. 8 that it had received clearance from the U.S. Food and Drug Administration (FDA) to test its genetically engineered pig kidneys on humans with chronic kidney disease.

eGenesis' new kidney is called the EGEN-2784.

“Clearance of the EGEN-2784 and initiation of this clinical study are important steps forward in ou

See Full Page